Shilajit D Kundu

My research focuses on strategies to diagnose and characterize bladder cancer, novel strategies to characterized prostate cancer aggressiveness, and prospectively studying quality of life outcomes in patients with urologic cancers.

I have successfully conducted and published on prospective evaluations of patients with urologic cancers including prostate, bladder, kidney and testicular cancer and have found that the impact of cancer treatment goes beyond physical limitations associated with treatment. My recent research aims to understand the complexities associated with patient expectations. This includes balancing factors associated with patient satisfaction including patient personality, physician-patient relationship, information-processing style, and a comforting experience with the health care environment. Dr. Kundu’s research focuses include treatment of bladder cancer, kidney cancer, urinary tract cancer, prostate cancer, robotic prostatectomy, robotic nephrectomy, and cancer genetics.

My clinical interests include bladder cancer, continent urinary diversions for bladder cancer, multimodal therapy for advanced cancers including surgical therapy for bladder cancer, prostate cancer, kidney cancer, testis cancer, robotic surgery for bladder cancer, and testis cancer treatment.